Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esmolol versus dexmedetomidine for deliberate hypotension during functional endoscopic sinus surgery
PACTR201801002878287Not yet recruiting
- Sponsor
- Menoufia University
- Start
- Jan 2018
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Trial of esmolol and dexmedetomidine in chronic rhinosinusitis (CRS) (2 arms), sponsored by Menoufia University. Primary endpoint: Total blood loss during operation. Planned start Jan 2018; status: not yet recruiting.
02
Drugs
esmololdexmedetomidine
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on PACTR201801002878287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201801002878287.